✦ LIBER ✦

28-Day safety and tolerability of umeclidinium in combination with vilanterol in COPD: A randomized placebo-controlled trial

✍ Scribed by Gregory Feldman; Robert R. Walker; Jean Brooks; Rashmi Mehta; Glenn Crater

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, placebo- and moxifloxacin-

✍ Kelleher, Dennis; Tombs, Lee; Preece, Andrew; Brealey, Noushin; Mehta, Rashmi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 502 KB

Safety and tolerability of indacaterol i

✍ Alexander G. Chuchalin; Alla N. Tsoi; Kai Richter; Norbert Krug; Ronald Dahl; P. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 622 KB

Safety, tolerability and efficacy of ind

✍ Jutta Beier; Pascal Chanez; Jean-Benoit Martinot; A.J.M. Schreurs; Ružena Tkáčov 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Roflumilast in Asian patients with COPD:

✍ SANG-DO LEE; DAVID S. C. HUI; AZIAH A. MAHAYIDDIN; CAMILO C. ROA JR; KHENG HOE K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

Tolerability of indacaterol, a novel onc

✍ Yang, William H.; Martinot, Jean Benoit; Pohunek, Petr; Beier, Jutta; Magula, Da 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Efficacy and safety of umeclidinium plus

✍ Decramer, Marc; Anzueto, Antonio; Kerwin, Edward; Kaelin, Thomas; Richard, Natha 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 272 KB